Galvin Gaustad & Stein LLC Has $12.21 Million Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Galvin Gaustad & Stein LLC reduced its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 33.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 156,123 shares of the company’s stock after selling 77,944 shares during the quarter. Galvin Gaustad & Stein LLC’s holdings in GE HealthCare Technologies were worth $12,206,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. LGT Financial Advisors LLC raised its holdings in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares during the period. Fred Alger Management LLC acquired a new stake in GE HealthCare Technologies in the second quarter worth $26,000. Capital Performance Advisors LLP acquired a new stake in GE HealthCare Technologies in the third quarter worth $26,000. Ashton Thomas Securities LLC acquired a new stake in GE HealthCare Technologies in the third quarter worth $26,000. Finally, Darwin Wealth Management LLC bought a new stake in shares of GE HealthCare Technologies during the third quarter worth $31,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.27% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $87.26 on Thursday. The company has a fifty day moving average price of $82.08 and a two-hundred day moving average price of $84.58. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The stock has a market cap of $39.86 billion, a P/E ratio of 23.97, a P/E/G ratio of 2.88 and a beta of 1.11. GE HealthCare Technologies Inc. has a one year low of $71.31 and a one year high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.06 by $0.08. The company had revenue of $4.86 billion during the quarter, compared to analysts’ expectations of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. GE HealthCare Technologies’s quarterly revenue was up .9% compared to the same quarter last year. During the same quarter last year, the company posted $0.99 EPS. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. The ex-dividend date is Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on GEHC shares. Stifel Nicolaus increased their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research report on Monday, September 30th. Wells Fargo & Company increased their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Evercore ISI increased their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their price objective for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $96.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.